1. Antenatal noninvasive treatment of patients at risk for alloimmune thrombocytopenia without a history of intracranial hemorrhage
- Author
-
Yinon, Yoav, Spira, Maya, Solomon, Ofira, Weisz, Boaz, Chayen, Benjamin, Schiff, Eyal, and Lipitz, Shlomo
- Subjects
Thrombocytopenia -- Care and treatment ,Immunoglobulins ,Health - Abstract
To link to full-text access for this article, visit this link: http://dx.doi.org/10.1016/j.ajog.2006.06.066 Byline: Yoav Yinon (a), Maya Spira (a), Ofira Solomon (b), Boaz Weisz (a), Benjamin Chayen (a), Eyal Schiff (a), Shlomo Lipitz (a) Abstract: The purpose of this study was to evaluate noninvasive management of alloimmune thrombocytopenia that included only the blind administration of immunoglobulin. Author Affiliation: (a) Department of Obstetrics and Gynecology, the Chaim Sheba Medical Center (b) Department of Hematology, Amalia Biron Research Institute of Thrombosis and Hemostasis, the Chaim Sheba Medical Center, Tel-Hashomer, affiliated to the Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel Article History: Received 9 March 2006; Revised 31 May 2006; Accepted 17 June 2006 Article Note: (footnote) Presented at the 26th Annual Meeting of the Society for Maternal Fetal Medicine, January 30-February 4, 2006, Miami, Florida.
- Published
- 2006